IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Calliditas Therapeutics AB

CUSIP: 13124Q106 | 64 institutional holders

Quarters

Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023
CompareDetailedHistoricalFundsOptions13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q3 2024

Crossmark Global Holdings, Inc.16,117
0.0% of portfolio›$655
Advisors Preferred, LLC2,022
0.0% of portfolio›$81.5K
Simplex Trading, LLC1,826
0.0% of portfolio›$0
Rhumbline Advisers303
0.0% of portfolio›$12.2K
Missouri Trust & Investment Co35
0.0% of portfolio›$1.4K
StyleTurnoverLocationFiled
Crossmark Global Holdings, Inc.
16,117$6550.0%GARPMediumHouston, TX2024-11-04
Advisors Preferred, LLC
2,022$81.5K0.0%ETFVery HighRockville, MD2024-10-15
Simplex Trading, LLC
1,826$00.0%CoreVery HighChicago, IL2024-11-08
Rhumbline Advisers
303$12.2K0.0%IndexVery LowBoston, MA2024-11-12
Missouri Trust & Investment Co
35$1.4K0.0%CoreVery LowSpringfield, MO2024-11-05